The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of acoramidis in the EU based on positive results from the ...

Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications.

The UK government has announced an indefinite ban on the use of puberty blockers for treating under 18s with gender dysphoria, after the Commission on Human Medicines advised that continuing to allow ...

The European Commission (EC), which has the authority to approve ... today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has... at ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

This week, it was announced that puberty blocking medication will be banned for under-18s with gender dysphoria indefinitely ...

Galderma today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting the marketing ...

2 IL-31 is a neuroimmune cytokine that drives itch and is involved in inflammation and skin barrier dysfunction in both atopic dermatitis and prurigo nodularis 11-13 This positive opinion from the ...

Pauline Hanson is calling on the government to issue an immediate ban on puberty blockers for the treatment of gender ...

Olivér Várhelyi's tempestuous confirmation process has seen pandemic preparedness and reproductive health stripped from his ...

The ruling comes as the Supreme Court is poised to uphold a similar Tennessee law and as the U.K. made efforts to ban minors ...